Optimal Dose Selection of ADG126 (a Masked anti-CTLA-4 SAFEbody(r)) with Significantly Widened Therapeutic Index compared to Ipilimumab in Combination with anti-PD-1 Antibodies Informed by QSP Modeling
ADG126;Ipilimumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Optimal Dose Selection of ADG126 (a Masked anti-CTLA-4 SAFEbody(r)) with Significantly Widened Therapeutic Index compared to Ipilimumab in Combination with anti-PD-1 Antibodies Informed by QSP Modeling ### Output: ADG126;Ipilimumab